MARKETS
Markets

Helus Pharma Appoints Mark Lawson As Board Chair, Effective Immediately

Oct 27, 2026 · 08:10 AM ET· updated 1h ago

Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (the "Company" or "Helus Pharma"), a clinical-stage pharmaceutical company committed to improving the treatment landscape in mental health through the

Share
Why It Matters

Helus Pharma brought in a new leader for its board of directors right away. When companies make leadership changes, watch if the new person brings fresh energy and ideas to the company's work.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.